- AU$65.41m
- AU$916.50m
- AU$144.97m
Brief: Harmoney Considers Inorganic Growth Opportunities Including Potential Acquisitions
Brief: Harmoney Corp Provides 3Q26 Trading Update
Brief: Harmoney Corp Posts HY Total Income A$71.9 Million
ASX-listed Harmoney Corp soars on robust loan book
Brief: Harmoney Corp Executed A$15 Mln Revolving Corporate Debt Facility
Brief: Harmoney Corp Says Founder Sold 3.6 Million Shares In Co
New Zealand's Harmoney Corp surges on upgrading forecast, announcing buy-back
Brief: Harmoney Corp Upgrades Cash NPAT Guidance To A$5.5 Mln For Fy25
ASX-listed Harmoney Corp gains on upbeat earnings outlook
Brief: Harmoney Corp Says Q1 Net Interest Margin On Loan Book Rose To 8.9%
New Zealand's Harmoney falls on wider FY loss
Brief: Harmoney Says FY Revenue From Ordinary Activities A$122.5 Million
Brief: Harmoney Corp Sees Net Interest Margin Returning To 9% In 2H25
Brief: Harmoney Corp Says 9-Month Revenue A$91 Million
U.S. STOCKS ON THE MOVE-US Health Insurers, Palisade Bio, Dynatronics
Brief: Harmoney Corp Sees Net Interest Margin Of 9% In FY24
Brief: Harmoney Corp Announces Refinancing And Upsize Of Its Corporate Debt Facility
Fy24 Outlook Reaffirmed.
Brief: Harmoney Corp Posts FY Net Loss Attributable Of A$7.6 Million